Cargando…
Biomarkers and recent advances in the management and therapy of sickle cell disease
Although production of hemoglobin S, the genetic defect that causes sickle cell disease (SCD), directly affects only red blood cells, the manifestations of SCD are pervasive, and almost every cell type and organ system in the body can be involved. Today, the vast majority of patients with SCD who re...
Autor principal: | Telen, Marilyn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963010/ https://www.ncbi.nlm.nih.gov/pubmed/27508053 http://dx.doi.org/10.12688/f1000research.6615.1 |
Ejemplares similares
-
Pyridoxamine: another vitamin for sickle cell disease?
por: Telen, Marilyn J.
Publicado: (2020) -
The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases
por: Chen, Shao-Yin, et al.
Publicado: (2008) -
Validation of a novel point of care testing device for sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2015) -
Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
por: Migotsky, Michael, et al.
Publicado: (2022) -
Recent Advances in the Treatment of Sickle Cell Disease
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2020)